[Answered] Which insurance claim is submitted to receive reimbursement under Medicare Part C? a. CMS-1500 b. ...

This topic contains a solution. Click here to go to the answer

Author Question: Which insurance claim is submitted to receive reimbursement under Medicare Part C? a. CMS-1500 b. ... (Read 123 times)

Medesa

Hero Member
Posts: 507

on: Jun 27, 2018

Which insurance claim is submitted to receive reimbursement under Medicare Part C?
a. CMS-1500
b. CMS-1500 or UB-04
c. UB-92
d. UB-04

Question 2

Which insurance claim is submitted to receive reimbursement under Medicare Part B?
a. CMS-1450
b. CMS-1500
c. UB-92
d. UB-04

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

jaykayy05

Sr. Member
Posts: 329

Reply #1 on: Jun 27, 2018

Answer to Question 1

b

Answer to Question 2

b

Medesa

Member
Posts: 507

Reply 2 on: Jun 27, 2018

Gracias!

yeungji

Member
Posts: 319

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.